nference

nference is proud to support Blueprint Medicines in their mission to better understand the real-world burden and natural history of #ISM. Leveraging our #AI platform, researchers from Blueprint Medicines, Mayo Clinic and nference were able to analyze de-identified electronic health record data. The study revealed significant differences in healthcare utilization and #allergy prevalence for patients with ISM compared to matched controls. The findings that were presented today at #AAAAI25 reflect the importance of longitudinal real-world data in understanding the disease burden on ISM patients. Learn more about the AI platform powering breakthrough clinical research: https://lnkd.in/eqWTyzTd #Mastocytosis #RWE #PrecisionMedicine #AIinHealthcare #EHR

In our efforts to truly understand the experiences of people living with indolent systemic #mastocytosis (ISM), we work with partners to collect and analyze real-world data that inform our ability to improve and extend patients’ lives. At #AAAAI25 today, we're presenting findings from a study in partnership Dr. Thanai Pongdee to evaluate the real-world disease burden and natural history of ISM. This study involves the analysis of de-identified electronic health record data from the Mayo Clinic Platform via the nference Analytics Platform. Learn more below:

nference is sponsoring PMWC - Precision Medicine World Conference! Join nference at Booth #B803 this week to see a live demo of our #multimodal AI platform, nSights. Connect with our team today: Aaron Mathias Michiel JM Niesen Sadhna Kohli Jordan Sanford Kimberly Gasuad At nference, we’re committed to revolutionizing clinical research by combining advanced #AI models with comprehensive, de-identified multimodal data to unlock faster, more accurate outcomes. Our real-world evidence (#RWE) solutions—built in partnership with leading healthcare institutions—empower researchers to optimize #ClinicalTrial design, refine recruitment, and accelerate time-to-insight for novel therapies. Learn more about nference and how our AI-driven #nSights platform is transforming clinical research with real-world data: nference.com Request a live demo of the #nSights platform: https://lnkd.in/eqWTyzTd #PrecisionMedicine #ClinicalResearch #AIinHealthcare #RWD #LifeSciences #Genomics Tal Behar

Over 50% of new medicines face lengthy clinical trials, delaying patient access to breakthrough treatments. Leveraging #AI and advanced data platforms can significantly shorten the timeline for crucial efficacy readouts—bringing innovations to patients faster. nference’s Senior Director of Biomedical Research, Michiel JM Niesen, Ph.D., will join a distinguished panel at the PMWC - Precision Medicine World Conference on February 6th. The panel, titled “How to Implement AI for Faster Readouts of Clinical Trials,” will be chaired by William Oh, MD (Clinical Prof. of Medicine, Yale School of Medicine). Panel Participants: ? Jennifer Webster, VP, RWE Platforms & Partnerships at Pfizer ? Brandon Allgood, Ph.D., Chief Data Science Officer at Parabilis Medicines ? Julian Hong, MD, Assoc. Prof. & Medical Dir. of Radiation Oncology Informatics at University of California, San Francisco This forward-looking discussion will take place in the 'AI Models for RWE/D Applications' track, highlighting how AI tools, real-world data (#RWD), and collaborative platforms can accelerate #ClinicalTrial insights without compromising patient privacy. The nference team will be at Booth #B803 next week showcasing live demos of our #multimodal AI platform, nSights. Connect with our team to schedule a demo: Sadhna Kohli Jordan Sanford Kimberly Gasuad At nference, we’re committed to revolutionizing clinical research by combining advanced AI models with comprehensive, de-identified multimodal data to unlock faster, more accurate outcomes. Our real-world evidence solutions—built in partnership with leading healthcare institutions—empower researchers to optimize trial design, refine recruitment, and accelerate time-to-insight for novel therapies. Learn more about nference and how our AI-driven #nSights platform is transforming clinical research with real-world data: nference.com Request a live demo of our #nSights platform: https://lnkd.in/eqWTyzTd #PrecisionMedicine #ClinicalResearch #AIinHealthcare #RWE #LifeSciences #Genomics Tal Behar

Did you know? Over 1.5 million people worldwide are diagnosed with #BloodDisorders such as leukemia, lymphoma, and anemia each year. This underscores the urgent need for cutting-edge research and innovative treatments in hematology. Join nference at the American Society of Hematology (ASH) Annual Meeting this weekend to learn how we are advancing hematology research through real-world evidence and AI-driven insights. The ASH Annual Meeting is the premier event for leading experts, researchers, and clinicians to share breakthroughs in #Hematology research and patient care. Visit Booth #1557 to: ? Discover our federated data platform: Learn how we integrate fully de-identified longitudinal, #Multimodal data to tackle complex challenges in hematology, from rare blood disorders to hematologic malignancies. ? Leverage real-world evidence: Explore how our platform enhances #ClinicalTrial design, accelerates biomarker discovery, and improves patient care while maintaining the highest standards of data privacy and security. ? Experience a live demo: See our #nSights platform in action—combining AI insights from clinical notes, imaging, genomics, and laboratory data to deliver actionable, real-world evidence (#RWE). Connect with nference leaders: Aaron Mathias, VP, Business Development & Corporate Strategy AJ Venkatakrishnan, PhD, SVP,? A.I. Partnerships Sadhna Kohli, PhD, Director, Scientific Solutions Michiel JM Niesen, PhD, Senior Director of Biomedical Research Bruce Johnson, Biotech and Pharma Executive Allison Smither, PhD, Lead Research Scientist At nference, we are proud to partner with world-class institutions, including Mayo Clinic and Duke Health, to unlock the potential of de-identified healthcare data. Together, we are accelerating precision medicine and improving patient outcomes in difficult to treat and diagnose blood disorders. We look forward to connecting with you at #ASH to explore how our platform can support your research and clinical programs. Learn more about nference and our federated #nSights platform that is transforming healthcare through real-world data and AI: nference.com Request a live demo of the nSights #AI RWE platform: https://lnkd.in/eqWTyzTd #ASH2024 #HematologyInnovation #RealWorldEvidence #PrecisionMedicine #nference #AIinHealthcare

John Halamka, President of Mayo Clinic Platform Mayo Clinic describes four new #AI tools that are making #healthcare more powerful, more accurate and more #equitable. Learn more about how digital #technology, #data and AI can transform #health systems in the World Economic Forum report, Transforming Healthcare: Navigating Digital Health with a Value-Driven Approach:?https://ow.ly/kTXX50Ua7nA #HealthEquity

Congrats to the Anumana team for the latest recognition, this time from Fast Company’s ‘The 8 Next Big Technologies in Health for 2024” https://lnkd.in/efaM5j7J #Anumana - For #detecting #diseases #earlier Cardiovascular diseases remain the leading cause of death in the U.S. and across the globe. Anumana is tackling this by enhancing the utility of the electrocardiogram (ECG) with AI algorithms, so that clinicians can detect diseases earlier and more confidently. The ECG-AI algorithms were developed and trained using a real-world deep dataset from leading healthcare institutions and have been evaluated by the FDA.

Over 50% of #RareDisease cases go undiagnosed! Federated data platforms can unlock critical insights while preserving patient privacy, enabling more accurate disease diagnoses and accelerating the development of effective treatments. nference's SVP of Strategic AI Partnerships, AJ Venkatakrishnan, Ph.D., will participate in a distinguished panel discussion today hosted by Alexion Pharmaceuticals, Inc. The panel will address the critical role of federated data sharing in advancing research and treatment for rare diseases. Panel Participants: - Amit Gulwadi, VP Head of Transformation - R&D at Alexion Pharmaceuticals, Inc. - Anders Tveteraas, Global Head, Patient Solutions and Services at Novartis - Jen Horonjeff, CEO at Savvy Cooperative By nature, rare diseases impact a limited portion of the population, presenting unique challenges in data collection and analysis due to the small number of cases distributed across diverse geographies. #Federated data enables collaboration across institutions while preserving data and patient privacy, ultimately leading to a more comprehensive understanding of rare diseases and fostering the development of innovative therapies. nference is dedicated to advancing the understanding of complex diseases, including rare conditions. Our federated data platform—created in partnership with leading healthcare institutions including the Mayo Clinic and Duke Health—enables unparalleled access to fully de-identified multimodal data across millions of #longitudinal patient journeys. By combining insights from clinical notes, imaging, genomics, and other critical data modalities, nference empowers researchers to accelerate discovery, optimize #clinicaltrials, and enhance patient care, unlocking new possibilities for rare disease research and treatment. Event details: https://lnkd.in/eA-28mmS Learn more about nference and our federated #nSights platform that is transforming healthcare through real-world data and AI: nference.com Request a live demo of our nSights platform: https://lnkd.in/eqWTyzTd #RareDiseaseResearch #FederatedData #FederatedLearning #nference #RealWorldEvidence #AlexionPharmaceuticals HLTH Inc.

We incorporate data science into all elements of our Helicon discovery platform. Now, we’re excited to announce a new partnership that will greatly expand our ability to deploy these tools throughout clinical drug development. We’re teaming up with nference to utilize nference’s proprietary nSights platform to advance the development of FOG-001, our clinical-stage investigational therapy for the treatment of colorectal cancer and other solid tumors.? ? Through nference’s vast database of real-world patient data, and their custom-built AI and machine learning models, we’ll be able to run more efficient clinical trials and improve the targeting of our programs — with the ultimate goal of improving the precision and success of our pipeline of potentially extraordinary medicines.?? ??? Read the full press release here:?https://bit.ly/3ARcWDI ? ?? #CreatingExtraordinaryMedicines #Biotech #Oncology

Today, nference announced a strategic research and data science partnership with Parabilis Medicines focused on accelerating the clinical development of Parabilis’ lead program, FOG-001, in colorectal cancer. This partnership will grant Parabilis access to nference’s extensive repository of de-identified longitudinal, #multimodal clinical data, sourced from leading healthcare institutions, to support their precision medicine efforts. Through the nSights platform, nference’s advanced machine learning models will provide insights to contextualize Parabilis’ clinical trial data, enabling identification of clinical #biomarkers and real-world patient outcomes. The partnership aims to optimize patient cohort selection and enhance the targeting capabilities of FOG-001, a beta-catenin inhibitor now in a Phase 1/2 trial for colorectal cancer. “The nSights platform will enable us to tap into a large depth of real-world, multimodal clinical data, helping us identify optimal patient populations and improve the targeting of our programs. By combining advanced #AI, robust computational methods, and a continuous learning system built on our growing data repository, we are creating a transformative platform that not only accelerates drug discovery and development but also increases the precision and success of our therapeutic programs,” said Dr. Brandon Allgood, Chief Data Science Officer at Parabilis. Read the press release: https://lnkd.in/ekHTGAHW Learn more about nference and our software platform that is transforming healthcare through real-world data and AI: nference.com Request a live demo of our AI software platform: https://lnkd.in/eqWTyzTd #nference #RealWorldData #PrecisionMedicine #ColorectalCancer #Parabilis #ClinicalData #CancerResearch